Goodwin Biotechnology, Inc. to Exhibit at Biotechnology Industry Organization (BIO) International Convention, May 19 to 21, 2009 at Booth 5114

PLANTATION, Fla.--(BUSINESS WIRE)--Goodwin Biotechnology Inc. (GBI) is a cGMP compliant contract manufacturing organization (CMO) that assists companies in developing monoclonal antibodies and recombinant proteins expressed in mammalian cell culture systems. GBI has been in the business of manufacturing therapeutic antibodies since 1993, and its focus is to provide services that are regulatory compliant, scalable, and cost effective. GBI is fully integrated and its “fast track” manufacturing strategies have enabled the Company to deliver vialed clinical product to clients in as little as seven months after transfer of a cell line to GBI. Services offered by GBI include clone selection, media studies, cell banking, upstream and downstream process development, stirred tank and perfusion bioreactor production systems, purification, protein conjugation and aseptic filling. These services are offered in support of clients’ projects or each individually as stand-alone services. GBI’s manufacturing activities are supported by in-house Quality Control labs which provide analytical testing and ICH stability studies. A Project Manager is assigned to each client and acts as the single point of contact between GBI and the clients’ organizations. GBI’s unparalleled Regulatory support includes preparation of CMC sections for IND applications (or foreign equivalents), and distribution of your product to clinical trial sites.